[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019

December 2019 | 152 pages | ID: S929162B98DCEN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019' provides an overview of Spinal Cord Stimulators (SCS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators (SCS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Spinal Cord Stimulators (SCS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Spinal Cord Stimulators (SCS) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
3.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
3.3 Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
3.4 Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
3.5 Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials

4 SPINAL CORD STIMULATORS (SCS) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
4.2 Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development

5 SPINAL CORD STIMULATORS (SCS) COMPANIES AND PRODUCT OVERVIEW

5.1 Boston Scientific Corp Company Overview
  5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Cerevast Therapeutics Inc Company Overview
  5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Direct Spinal Therapeutics, Inc. Company Overview
  5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Duke University Company Overview
  5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.5 GTX Medical BV Company Overview
  5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Imperial College London Company Overview
  5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.7 Lawson Health Research Institute Company Overview
  5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.8 Meagan Medical Inc. Company Overview
  5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic plc Company Overview
  5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Micro-Leads Inc Company Overview
  5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 MicroTransponder Inc Company Overview
  5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Neuronoff Inc Company Overview
  5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Nevro Corp Company Overview
  5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Nexstim Plc Company Overview
  5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Nuvectra Corp Company Overview
  5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 Saluda Medical Pty Ltd Company Overview
  5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Soterix Medical Inc Company Overview
  5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 SpineX Company Overview
  5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview
5.19 St. Jude Medical LLC Company Overview
  5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of California Los Angeles Company Overview
  5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Minnesota Company Overview
  5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.22 Wavegate Technologies LLC Company Overview
  5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 WISE s.r.l. Company Overview
  5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

6 SPINAL CORD STIMULATORS (SCS)- RECENT DEVELOPMENTS

6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11
6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Table 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Table 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Table 6: Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
Table 7: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation SCS System - Product Status
Table 10: Next Generation SCS System - Product Description
Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transdermal Electrical Neurostimulation Device - Product Status
Table 13: Transdermal Electrical Neurostimulation Device - Product Description
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Iowa-Patch System - Product Status
Table 16: Iowa-Patch System - Product Description
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Spinal Cord Stimulator - Product Status
Table 19: Spinal Cord Stimulator - Product Description
Table 20: GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: External Transcutaneous Spinal Cord Stimulation Device - Product Status
Table 22: External Transcutaneous Spinal Cord Stimulation Device - Product Description
Table 23: Targeted Epidural Spinal Stimulation Device - Product Status
Table 24: Targeted Epidural Spinal Stimulation Device - Product Description
Table 25: GTX Medical BV - Ongoing Clinical Trials Overview
Table 26: External Transcutaneous Spinal Cord Stimulation Device - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
Table 27: Targeted Epidural Spinal Stimulation Device - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
Table 28: Targeted Epidural Spinal Stimulation Device - Enabling Forelimb Function with Agonist Drug and Epidural Stimulation in SCI
Table 29: Targeted Epidural Spinal Stimulation Device - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 30: Targeted Epidural Spinal Stimulation Device - Task and Physiological Specific Stimulation for Recovery of Autonomic Function, Voluntary Movement, and Standing Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 31: Targeted Epidural Spinal Stimulation Device - Task-specific Epidural Stimulation and Training for Recovery of Stepping, Standing and Voluntary Movement Following Severe Spinal Cord Injury
Table 32: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Wireless Intraspinal Microstimulation System - Product Status
Table 34: Wireless Intraspinal Microstimulation System - Product Description
Table 35: Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Spinal Implant - Parkinson’s Disease - Product Status
Table 37: Spinal Implant - Parkinson’s Disease - Product Description
Table 38: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DISCSS IFC System - Product Status
Table 40: DISCSS IFC System - Product Description
Table 41: Meagan Medical Inc. - Ongoing Clinical Trials Overview
Table 42: DISCSS IFC System - Pilot Study to Examine the Feasibility of the DISCSS
Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: MRI Surgical Lead - Product Status
Table 45: MRI Surgical Lead - Product Description
Table 46: Next Generation Intellis - Product Status
Table 47: Next Generation Intellis - Product Description
Table 48: PrimeADVANCED - Heart Failure - Product Status
Table 49: PrimeADVANCED - Heart Failure - Product Description
Table 50: Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: HD64 Implantable Therapy System - Product Status
Table 52: HD64 Implantable Therapy System - Product Description
Table 53: Intelligent Spinal Interface - Product Status
Table 54: Intelligent Spinal Interface - Product Description
Table 55: MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: SAINT System - Chronic Pain - Product Status
Table 57: SAINT System - Chronic Pain - Product Description
Table 58: Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Injectrode - Product Status
Table 60: Injectrode - Product Description

LIST OF FIGURES

Figure 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Figure 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Figure 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Figure 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Figure 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials

COMPANIES MENTIONED

Boston Scientific Corp
Cerevast Therapeutics Inc
Direct Spinal Therapeutics, Inc.
Duke University
GTX Medical BV
Imperial College London
Lawson Health Research Institute
Meagan Medical Inc.
Medtronic plc
Micro-Leads Inc
MicroTransponder Inc
Neuronoff Inc
Nevro Corp
Nexstim Plc
Nuvectra Corp
Saluda Medical Pty Ltd
Soterix Medical Inc
SpineX
St. Jude Medical LLC
University of California Los Angeles
University of Minnesota
Wavegate Technologies LLC
WISE s.r.l.


More Publications